These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 1847458

  • 1. Identification of two determinants that attenuate vaccine-related type 2 poliovirus.
    Ren RB, Moss EG, Racaniello VR.
    J Virol; 1991 Mar; 65(3):1377-82. PubMed ID: 1847458
    [Abstract] [Full Text] [Related]

  • 2. Mapping of attenuating sequences of an avirulent poliovirus type 2 strain.
    Moss EG, O'Neill RE, Racaniello VR.
    J Virol; 1989 May; 63(5):1884-90. PubMed ID: 2539491
    [Abstract] [Full Text] [Related]

  • 3. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.
    Macadam AJ, Pollard SR, Ferguson G, Skuce R, Wood D, Almond JW, Minor PD.
    Virology; 1993 Jan; 192(1):18-26. PubMed ID: 8390752
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell.
    Couderc T, Hogle J, Le Blay H, Horaud F, Blondel B.
    J Virol; 1993 Jul; 67(7):3808-17. PubMed ID: 8389907
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients.
    Li J, Zhang LB, Yoneyama T, Yoshida H, Shimizu H, Yoshii K, Hara M, Nomura T, Yoshikura H, Miyamura T, Hagiwara A.
    Arch Virol; 1996 Jul; 141(6):1047-54. PubMed ID: 8712922
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses.
    Mattion NM, Reilly PA, DiMichele SJ, Crowley JC, Weeks-Levy C.
    J Virol; 1994 Jun; 68(6):3925-33. PubMed ID: 8189529
    [Abstract] [Full Text] [Related]

  • 20. Development of candidates for new type 2 and type 3 oral poliovirus vaccines.
    Kohara M, Abe S, Yoshioka I, Nomoto A.
    Dev Biol Stand; 1993 Jun; 78():141-8. PubMed ID: 8388824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.